The US Food and Drug Administration (FDA) on Monday evening issued two guidances intended to accelerate the development of products to treat or prevent coronavirus disease (COVID-19), laying out ...

The COVID-19 pandemic may be viewed as the single largest disruptor in the history of American healthcare. At Geisinger, the crisis has been a catalyst to accelerate digital transformation. In January ...

The US Food and Drug Administration (FDA) on Tuesday detailed a new “special emergency program” for accelerating research and development of potential treatments for coronavirus disease (COVID-19).

A group of scientists, physicians, funders, and policy makers from over 70 institutions from over 30 countries have launched an international coalition to respond to COVID-19 in resource-poor settings ...

Two bills – one in Idaho, the other in the U.S. Senate – defy science, logic, and civic responsibility. The first would criminalize the administration of life-saving mRNA vaccines, while the second ...

COVID summer wave 2026 has reached all 50 states as two wastewater networks issue opposite readings: CDC rates national ...

As blood vessels ages, it can make arteries stiffer -- raising the risk of cardiovascular disease, including stroke and heart attack, explained the researchers. "We know that Covid can directly affect ...